PubMed

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.

Ratziu V, Thibault V, Benhamou Y, Poynard T.

Comp Hepatol. 2006 Jan 11;5:1.PMID: 16405720 [PubMed]Related articlesFree article

In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

Qi X, Xiong S, Yang H, Miller M, Delaney WE 4th.

Antivir Ther. 2007;12(3):355-62.PMID: 17591025 [PubMed - indexed for MEDLINE]Related articles

[Resistance to adefovir in patients with chronic hepatitis B]

Ryu SH, Chung YH.

Korean J Hepatol. 2006 Dec;12(4):484-92. Review. Korean. PMID: 17237626 [PubMed - indexed for MEDLINE]Related articlesFree article

Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient.

Katsounas A, Jochum C, Canbay A, Schlaak J, Gerlich WH, Gerken G.

Eur J Med Res. 2008 Oct 27;13(10):472-5.PMID: 19008175 [PubMed - indexed for MEDLINE]Related articles

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yatsuji H, Suzuki F, Sezaki H, Akuta N, Suzuki Y, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Kobayashi M, Kumada H.

J Hepatol. 2008 Jun;48(6):923-31. Epub 2008 Apr 1.PMID: 18433925 [PubMed - indexed for MEDLINE]Related articles

Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.

Villet S, Pichoud C, Billioud G, Barraud L, Durantel S, Trépo C, Zoulim F.

J Hepatol. 2008 May;48(5):747-55. Epub 2008 Feb 25.PMID: 18331765 [PubMed - indexed for MEDLINE]Related articles

[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients]

Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW.

Korean J Hepatol. 2008 Mar;14(1):58-66. Korean. PMID: 18367858 [PubMed - indexed for MEDLINE]Related articlesFree article

Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment.

Kwon SY, Choe WH, Lee CH, Yeon JE, Byun KS.

World J Gastroenterol. 2008 Jul 21;14(27):4416-9.PMID: 18666338 [PubMed - indexed for MEDLINE]Related articlesFree article

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.

Choe WH, Kwon SY, Kim BK, Ko SY, Yeon JE, Byun KS, Kim GH, Lee CH.

Liver Int. 2008 Jul;28(6):814-20.PMID: 18312291 [PubMed - indexed for MEDLINE]Related articles

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

Villet S, Pichoud C, Villeneuve JP, Trépo C, Zoulim F.

Gastroenterology. 2006 Oct;131(4):1253-61. Epub 2006 Aug 16.PMID: 17030194 [PubMed - indexed for MEDLINE]Related articles

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

Lampertico P, Viganò M, Manenti E, Iavarone M, Sablon E, Colombo M.

Gastroenterology. 2007 Nov;133(5):1445-51. Epub 2007 Sep 2.PMID: 17983801 [PubMed - indexed for MEDLINE]Related articles

Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment.

Joo MK, Yeon JE, Kim JH, Jung YK, Lee SJ, Kim JH, Yim HJ, Byun KS, Park JJ, Kim JS, Bak YT.

Scand J Gastroenterol. 2008;43(12):1514-21.PMID: 18663665 [PubMed - indexed for MEDLINE]Related articles

Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7.PMID: 18617782 [PubMed - indexed for MEDLINE]Related articles

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2006 Aug;44(2):318-25.PMID: 16871563 [PubMed - indexed for MEDLINE]Related articles

Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.

Zhang FK.

Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):10-5. Review.PMID: 16481275 [PubMed - indexed for MEDLINE]Related articlesFree article

Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.

Leemans WF, Janssen HL, Niesters HG, de Man RA.

J Viral Hepat. 2008 Feb;15(2):108-14.PMID: 18184193 [PubMed - indexed for MEDLINE]Related articles

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.

Zaaijer HL, Takkenberg RB, Weegink CJ, Rebers SP, Menting S, Reesink HW, Schinkel J, Molenkamp R.

J Med Virol. 2009 Mar;81(3):413-6.PMID: 19152408 [PubMed - indexed for MEDLINE]Related articles

The current management of HBV drug resistance.

Liaw YF.

J Clin Virol. 2005 Dec;34 Suppl 1:S143-6. Review.PMID: 16461216 [PubMed - indexed for MEDLINE]Related articles

Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.

Chen CH, Wang JH, Lee CM, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.

Antivir Ther. 2006;11(6):771-8.PMID: 17310821 [PubMed - indexed for MEDLINE]Related articles

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.

Tan J, Degertekin B, Wong SN, Husain M, Oberhelman K, Lok AS.

J Hepatol. 2008 Mar;48(3):391-8. Epub 2008 Jan 3.PMID: 18199519 [PubMed - indexed for MEDLINE]Related articles